PBS: Clinical Trials

26 trials of PBS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 recruiting, 3 unknown, 2 terminated. 11 Phase 2, 8 Phase 1, 5 Not applicable, 4 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 7, Unknown 2, Active not recruiting 1, Not yet recruiting 1
Phase 18Completed 7, Recruiting 1
Not applicable5Completed 2, Recruiting 1, Terminated 1, Unknown 1
Phase 34Completed 2, Not yet recruiting 1, Recruiting 1
Early Phase 11Terminated 1

Follow PBS: new trials by email Literature Review of PBS trials Research Report on PBS

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma
3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection - Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma
Phase 2 / Phase 3Not yet recruitingNational Cancer Institute (NCI)3742026-12-042026-07-08
BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
Biospecimen Collection, Dulbecco''s Phosphate-Buffered Saline, Peptide Vaccine - Chronic Kidney Disease, Stage 4, Chronic Kidney Disease, Stage 5
Phase 1RecruitingOhio State University Comprehensive Cancer Center552026-06-282026-07-02
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Pencil Beam Scanning - Astrocytoma, IDH-Mutant, Grade 3
Phase 3RecruitingAlliance for Clinical Trials in Oncology4082026-06-242026-10-02
Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
Denosumab, PBS - Female Infertility, NF-κB Ligand
Not applicableRecruitingPeter Humaidan1002025-08-012026-04-22
53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
TPX-100 200mg, Once weekly for 4 weeks, PBS - Osteoarthritis (OA) of the Knee
Phase 2Active not recruitingOrthoTrophix, Inc2702025-05-092026-02-17
WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction
Intravenous infusion placebo, Intravenous infusion WJMSCs - Acute Myocardial Infarction
Phase 2UnknownNavy General Hospital, Beijing2002020-11-012020-09-16
hCG-activated PBMC-therapy in RIF Patients
Peripheral Blood Monouclear Cell, Phosphate Baffer Saline - Recurrent Implantation Failure
Not applicableCompletedSCARM Institute, Tabriz, Iran1002017-10-072019-08-26
Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine
VCL-HB01, Phosphate-buffered saline - Herpes Genitalis
Phase 2CompletedVical2612016-09-012019-02-27
Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome
ACI-24 low dose, ACI-24 high dose, Placebo - Down Syndrome
Phase 1CompletedAC Immune SA202016-03-012021-10-15
Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis
CBLB612, Placebo - Breast Cancer
Phase 2CompletedBioLab 612 LLC232015-12-012016-07-20
Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer
CBLB502, Placebo - Colorectal Cancer
Phase 2UnknownBioLab 612 LLC402015-11-012017-02-09
Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy
PBS, TLH _adnexal preservation - Uterine Fibroids, Adenomyosis
Not applicableUnknownUniversity Magna Graecia1672014-02-012016-11-18
Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults
VCL-HB01, VCL-HM01, PBS - Genital Herpes Simplex Type 2
Phase 1 / Phase 2CompletedVical1652013-12-012019-02-27
Gel-One Treatment in Knee Osteoarthritis
Gel-One, PBS - Osteoarthritis Knee
Not applicableCompletedSeikagaku Corporation8142013-08-012023-03-23
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Durolane, PBS - Knee Osteoarthritis
Not applicableTerminatedGalderma R&D752012-12-012022-08-26
Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine
GEN-003 with Matrix M-2, GEN-003, Placebo - Genital Herpes Simplex Type 2
Phase 1 / Phase 2CompletedGenocea Biosciences, Inc.1432012-07-012018-06-01
Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma
Endothelin Receptor B inhibitor BQ788, PBS - Melanoma
Early Phase 1TerminatedMelCure SA52011-05-012015-05-20
Hymovis™ Versus Placebo in Knee Osteoarthritis
Hymovis Intra-articular Injection, Phosphate Buffered Saline Injection - Knee Osteoarthritis
Phase 3CompletedFidia Farmaceutici s.p.a.8002011-03-012014-04-08
Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever
TDV - Low Dose, TDV - High Dose, Placebo - Dengue Fever
Phase 1CompletedInviragen Inc.962010-10-112018-06-19
Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children
Dexmedetomidine, Saline - Agitation, Anesthesia
Phase 3CompletedSt. Luke's-Roosevelt Hospital Center332009-08-012018-11-27

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Herpes Simplex (3)  ·  Osteoarthritis (3)  ·  Osteoarthritis, Knee (3)  ·  Influenza in Birds (2)  ·  Influenza, Human (2)  ·  Adenomyosis (1)  ·  Alzheimer Disease (1)  ·  Astrocytoma (1)  ·  Breast Neoplasms (1)  ·  Cognitive Dysfunction (1)  ·  Colorectal Neoplasms (1)  ·  Dengue (1)  ·  Dermatitis, Atopic (1)  ·  Down Syndrome (1)  ·  Emergence Delirium (1)

Sponsors

Vical (4)  ·  BioLab 612 LLC (2)  ·  AC Immune SA (1)  ·  Aerovance, Inc. (1)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Fidia Farmaceutici s.p.a. (1)  ·  Galderma R&D (1)  ·  Genocea Biosciences, Inc. (1)  ·  Inviragen Inc. (1)  ·  MelCure SA (1)  ·  National Cancer Institute (NCI) (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Navy General Hospital, Beijing (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  OrthoTrophix, Inc (1)

Countries

United States (15)  ·  Colombia (1)  ·  Denmark (1)  ·  Iran (1)  ·  Italy (1)  ·  Japan (1)  ·  Puerto Rico (1)  ·  Russia (1)  ·  United Kingdom (1)

Top investigators

Don Guterwill, BS, MT (2)  ·  Aleksei G. Manikhas, MD PhD (1)  ·  Cynthia Secchieri, PhD (1)  ·  Darren Wilbraham, MBBS (1)  ·  Dmitrii A. Krasnozhon, MD PhD (1)  ·  Fulvio Zullo (1)  ·  Ivan D Velez, MD, Ph.D. (1)  ·  Jolie Narang, M.D. (1)  ·  Lian Ru Gao, MD (1)  ·  Mammen P Mammen, MD, FIDSA (1)  ·  Mammen P. Mammen, Jr., MD, FIDSA (1)  ·  Mehdi Yousefi, Ph.D (1)  ·  Michael S. Rafii, MD, PhD (1)  ·  Mohammad Nouri, Ph.D (1)

Results publications

PMID 11756389, PMID 12525435, PMID 14629021, PMID 15670421, PMID 16820110, PMID 17021188, PMID 19467808, PMID 2064208, PMID 22035703, PMID 22464086, PMID 23028125, PMID 23909917, PMID 2419430, PMID 24289920, PMID 24354307, PMID 24408973, PMID 25087476, PMID 25731629, PMID 25820067, PMID 26330458, PMID 26469146, PMID 28329211, PMID 29644875, PMID 29714875, PMID 35532913, PMID 37314061, PMID 42720126

NIH funding

R01AG047922 (1), U10CA180820 (1)